Precision Medicine Advocates Program
Meet the Cure Forward Precision Medicine Advocates
The Precision Medicine Advocates Team at Cure Forward is empowering the next generation of Patient Advocates to become champions of cancer research, clinical trial awareness, open data access, and genomic oncology principles. The Cure Forward Precision Medicine Advocates are dedicated to strengthening the delivery of precision medicine and clinical trials information, building actionable learning practices, and helping patients find the best treatment options for their cancer care. We believe that our Precision Medicine Advocates play a vital role in launching a sustained and informative conversation about the importance of clinical trials and precision medicine treatment options.
The Cure Forward Precision Medicine Advocates are recognized leaders in the cancer community. Covering topics like precision medicine and molecular testing, the Precision Medicine Advocates help patients become active participants in the treatment decision-making process by providing education, resources, and support for navigating the complex landscape of cancer care and clinical trials. They are an authentic and trusted resource for patients.
The Precision Medicine Advocates Team
Alicia Staley is the Patient Advocacy Manager at Cure Forward. She directs the Precision Medicine Advocates team and works with the Patient Guides to help cancer patients find clinical trials based on the patient’s genomic data. Helping cancer patients use social media and social networks to build powerful relationships with their care teams is her primary focus. Stop by the Cure Forward Facebook page to connect with her. She joined Cure Forward in January 2016. Learn more about Alicia.
Liza Bernstein is a three-time Cancer Survivor who uses Twitter and social media to extend her patient advocacy work by helping others become engaged/empowered patients and partners in their own care. She is a frequent contributor to and influencer of leading global healthcare tweetchats and conferences. Learn more about Liza.
Cynthia was diagnosed with multiple myeloma, a blood cancer, in 2008. At that time, her life took on a new direction. Cindy’s induction therapy stopped working after a few cycles and she proceeded with a stem cell transplant, which failed to put her into remission. Depressed and scared she continued her fight using newly FDA-approved targeted therapies. Cynthia continues treatment with a maintenance protocol. Learn more about Cynthia.
After being diagnosed with a brain tumor at age 13, Charlie abided by the watch-and-wait tactic for nearly five years before having an awake-craniotomy to remove a grade II astrocytoma in the left insula at age 17. A Michigan native now residing in Arizona, Charlie is a senior at Arizona State University. Read more about Charlie.
Jamie Holloway is a both a scientist and a survivor, earning her PhD in tumor biology from Georgetown University a few years before her own breast cancer diagnosis. Now living with no evidence of disease after treatment for early stage triple negative breast cancer, she bridges the gap between scientists and researchers as a Precision Medicine Advocate. Learn more about Jamie.
Casey covered her share of medical stories as a TV news field producer, and then she got a breast cancer diagnosis five days before Christmas in 2007. In addition to her ongoing work as a journalist, she’s a popular speaker on healthcare system transformation from the ground up. Learn more about Casey.
Dave Bjork is a lung cancer survivor who was diagnosed when he was 34 years old. He has spent the past 15 years advocating for patient education and cancer research. He connects individuals, businesses, academic institutions and other key influencers to forge strong partnerships in the fight against cancer. Learn more about Dave.